| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | +7.89% | +1.59% | +6.30% | +4.50% | — |
| 14d | 3 | +66.67% | +5.14% | +3.91% | +1.23% | +6.88% | — |
| 30d | 3 | +66.67% | +1.37% | +8.28% | -3.63% | -3.63% | — |
| 60d | 3 | +33.33% | -18.24% | +3.71% | -31.76% | -31.76% | — |
| 90d | 3(2 pending) | +0.00% | -26.34% | +12.09% | -38.43% | -38.43% | — |
| 180d | 3(3 pending) | — | — | — | — | — | — |
| 1y | 3(3 pending) | — | — | — | — | — | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 3,277 | $1.93 | $6.3K | 16,689 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 2,654 | $2.22 | $5.9K | 13,412 | Jun 15, 2026 | Jun 16, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 2,292 | $2.57 | $5.9K | 10,758 | May 29, 2026 | Jun 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 1,984 | $2.97 | $5.9K | 8,466 | May 15, 2026 | May 19, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 2,190 | $2.69 | $5.9K | 6,498 | Apr 30, 2026 | May 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 1,984 | $2.97 | $5.9K | 4,308 | Apr 15, 2026 | Apr 17, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASE Chief Financial Officer | 2,324 | $2.54 | $5.9K | 2,324 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 108,000 | — | — | 108,000 | Oct 1, 2025 | Oct 2, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 324,000 | — | — | 324,000 | Oct 1, 2025 | Oct 2, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,775,044 | — | — | 1,803,044 | Jul 24, 2025 | Jul 28, 2025 ↗ | View → |
| PCSA PROCESSA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 28,000 | — | — | 28,000 | Jul 16, 2024 | Jul 18, 2024 ↗ | View → |
| RMTI ROCKWELL MEDICAL, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Sep 9, 2022 | Sep 13, 2022 ↗ | View → |
| RMTI ROCKWELL MEDICAL, INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Sep 15, 2020 | Sep 15, 2020 ↗ | View → |
| RMTI ROCKWELL MEDICAL, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Sep 15, 2020 | Sep 15, 2020 ↗ | View → |